financetom
Business
financetom
/
Business
/
Booz Allen Hamilton Fiscal Q3 Adjusted Earnings, Revenue Increase; Fiscal 2025 Guidance Revised
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Booz Allen Hamilton Fiscal Q3 Adjusted Earnings, Revenue Increase; Fiscal 2025 Guidance Revised
Jan 31, 2025 4:35 AM

07:09 AM EST, 01/31/2025 (MT Newswires) -- Booz Allen Hamilton ( BAH ) reported fiscal Q3 adjusted earnings Friday of $1.55 per diluted share, up from $1.41 a year earlier.

Analysts polled by FactSet expected $1.52.

Revenue for the quarter ended Dec. 31 was $2.92 billion, compared with $2.57 billion a year earlier.

Analysts surveyed by FactSet expected $2.87 billion.

For fiscal 2025, the company said it now expects adjusted diluted EPS of $6.25 to $6.40, compared with its previous guidance range of $6.10 to $6.30, on revenue growth of 12% to 13% versus 11% to 13% growth rate anticipated previously.

Analysts polled by FactSet expect non-GAAP EPS of $6.30 on revenue of $12.03 billion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
LL Flooring Shares Rise Pre-Bell After Elections of F9 Board Nominees
LL Flooring Shares Rise Pre-Bell After Elections of F9 Board Nominees
Jul 11, 2024
06:11 AM EDT, 07/11/2024 (MT Newswires) -- LL Flooring Holdings ( LL ) shares were up over 12% in premarket activity Thursday after its shareholders elected all three nominees from the private equity firm F9 Investments. F9 Investments said late Wednesday that based on a preliminary tabulation of voting results, LL Flooring ( LL ) shareholders have elected Tom Sullivan,...
Novo Nordisk Gets Complete Response Letter from US FDA for Insulin Icodec Application
Novo Nordisk Gets Complete Response Letter from US FDA for Insulin Icodec Application
Jul 11, 2024
06:09 AM EDT, 07/11/2024 (MT Newswires) -- Novo Nordisk ( NVO ) said Wednesday that it has received a complete response letter from the US Food and Drug Administration regarding the company's biologics license application for insulin icodec as treatment of diabetes mellitus. The company said the letter includes requests related to insulin icodec's manufacturing process and its type 1...
France's Decathlon aims to bulk up via deals in evolving sports market
France's Decathlon aims to bulk up via deals in evolving sports market
Jul 11, 2024
PARIS (Reuters) - French sports retailer Decathlon is shopping for specialist brands to expand its business, capitalising on a post-pandemic shakeout in the industry that has made many firms attractive targets, CEO Barbara Martin Coppola said. The privately owned company known for its affordable sports gear bought German climbing retailer Bergfreunde in January for hundreds of millions of euros and...
Inside Goldman Sachs' expanding but risky financing engine
Inside Goldman Sachs' expanding but risky financing engine
Jul 11, 2024
NEW YORK (Reuters) - A Goldman Sachs bet put in place in 2021 on lending to private funds has helped drive record revenues in fixed-income financing. Now, the Wall Street bank is pushing even deeper into the growing but risky market. The fund finance unit, housed in the bank's global banking and markets division, lends money secured by different types...
Copyright 2023-2026 - www.financetom.com All Rights Reserved